These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 20231041)

  • 1. Simultaneous MRI diffusion and perfusion imaging for tumor delineation in prostate cancer patients.
    Groenendaal G; van den Berg CA; Korporaal JG; Philippens ME; Luijten PR; van Vulpen M; van der Heide UA
    Radiother Oncol; 2010 May; 95(2):185-90. PubMed ID: 20231041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Usefulness of diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging in the diagnosis of prostate transition-zone cancer.
    Yoshizako T; Wada A; Hayashi T; Uchida K; Sumura M; Uchida N; Kitagaki H; Igawa M
    Acta Radiol; 2008 Dec; 49(10):1207-13. PubMed ID: 19031184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamic contrast-enhanced magnetic resonance imaging for localization of recurrent prostate cancer after external beam radiotherapy.
    Haider MA; Chung P; Sweet J; Toi A; Jhaveri K; Ménard C; Warde P; Trachtenberg J; Lockwood G; Milosevic M
    Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):425-30. PubMed ID: 17881141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostate cancer screening: the clinical value of diffusion-weighted imaging and dynamic MR imaging in combination with T2-weighted imaging.
    Tanimoto A; Nakashima J; Kohno H; Shinmoto H; Kuribayashi S
    J Magn Reson Imaging; 2007 Jan; 25(1):146-52. PubMed ID: 17139633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate cancer detection: comparison of T2-weighted imaging, diffusion-weighted imaging, proton magnetic resonance spectroscopic imaging, and the three techniques combined.
    Chen M; Dang HD; Wang JY; Zhou C; Li SY; Wang WC; Zhao WF; Yang ZH; Zhong CY; Li GZ
    Acta Radiol; 2008 Jun; 49(5):602-10. PubMed ID: 18568549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Added value of breathhold diffusion-weighted MRI in detection of small hepatocellular carcinoma lesions compared with dynamic contrast-enhanced MRI alone using receiver operating characteristic curve analysis.
    Xu PJ; Yan FH; Wang JH; Lin J; Ji Y
    J Magn Reson Imaging; 2009 Feb; 29(2):341-9. PubMed ID: 19161186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) is a useful modality for the precise detection and staging of early prostate cancer.
    Hara N; Okuizumi M; Koike H; Kawaguchi M; Bilim V
    Prostate; 2005 Feb; 62(2):140-7. PubMed ID: 15389803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostate cancer detection with multi-parametric MRI: logistic regression analysis of quantitative T2, diffusion-weighted imaging, and dynamic contrast-enhanced MRI.
    Langer DL; van der Kwast TH; Evans AJ; Trachtenberg J; Wilson BC; Haider MA
    J Magn Reson Imaging; 2009 Aug; 30(2):327-34. PubMed ID: 19629981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathologic validation of a model based on diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging for tumor delineation in the prostate peripheral zone.
    Groenendaal G; Borren A; Moman MR; Monninkhof E; van Diest PJ; Philippens ME; van Vulpen M; van der Heide UA
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):e537-44. PubMed ID: 22197085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of functional imaging with pathology for tumor delineation in the prostate.
    Groenendaal G; Moman MR; Korporaal JG; van Diest PJ; van Vulpen M; Philippens ME; van der Heide UA
    Radiother Oncol; 2010 Feb; 94(2):145-50. PubMed ID: 20116116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of extraprostatic cancer by prostate specific antigen density, endorectal MRI, and biopsy Gleason score in clinically localized prostate cancer.
    Horiguchi A; Nakashima J; Horiguchi Y; Nakagawa K; Oya M; Ohigashi T; Marumo K; Murai M
    Prostate; 2003 Jun; 56(1):23-9. PubMed ID: 12746843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate cancer detection with 3 T MRI: comparison of diffusion-weighted imaging and dynamic contrast-enhanced MRI in combination with T2-weighted imaging.
    Kitajima K; Kaji Y; Fukabori Y; Yoshida K; Suganuma N; Sugimura K
    J Magn Reson Imaging; 2010 Mar; 31(3):625-31. PubMed ID: 20187206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiparametric MRI is helpful to predict tumor focality, stage, and size in patients diagnosed with unilateral low-risk prostate cancer.
    Delongchamps NB; Beuvon F; Eiss D; Flam T; Muradyan N; Zerbib M; Peyromaure M; Cornud F
    Prostate Cancer Prostatic Dis; 2011 Sep; 14(3):232-7. PubMed ID: 21423266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamic contrast-enhanced-magnetic resonance imaging evaluation of intraprostatic prostate cancer: correlation with radical prostatectomy specimens.
    Puech P; Potiron E; Lemaitre L; Leroy X; Haber GP; Crouzet S; Kamoi K; Villers A
    Urology; 2009 Nov; 74(5):1094-9. PubMed ID: 19773038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined diffusion-weighted and dynamic contrast-enhanced MRI for prostate cancer diagnosis--correlation with biopsy and histopathology.
    Kozlowski P; Chang SD; Jones EC; Berean KW; Chen H; Goldenberg SL
    J Magn Reson Imaging; 2006 Jul; 24(1):108-13. PubMed ID: 16767709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of locally recurrent prostate cancer after radiation therapy: incremental value of 3T diffusion-weighted MRI.
    Kim CK; Park BK; Lee HM
    J Magn Reson Imaging; 2009 Feb; 29(2):391-7. PubMed ID: 19161194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of prostate cancer in peripheral zone: comparison of MR diffusion tensor imaging, quantitative dynamic contrast-enhanced MRI, and the two techniques combined at 3.0 T.
    Li C; Chen M; Li S; Zhao X; Zhang C; Luo X; Zhou C
    Acta Radiol; 2014 Mar; 55(2):239-47. PubMed ID: 23892233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Quantitative dynamic MRI and localisation of non-palpable prostate cancer].
    Cornud F; Beuvon F; Thévenin F; Chauveinc L; Vieillefond A; Descazeaux A; Flam T
    Prog Urol; 2009 Jun; 19(6):401-13. PubMed ID: 19467459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The utility of magnetic resonance imaging and spectroscopy for predicting insignificant prostate cancer: an initial analysis.
    Shukla-Dave A; Hricak H; Kattan MW; Pucar D; Kuroiwa K; Chen HN; Spector J; Koutcher JA; Zakian KL; Scardino PT
    BJU Int; 2007 Apr; 99(4):786-93. PubMed ID: 17223922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thirty-two-channel coil 3T magnetic resonance-guided biopsies of prostate tumor suspicious regions identified on multimodality 3T magnetic resonance imaging: technique and feasibility.
    Hambrock T; Fütterer JJ; Huisman HJ; Hulsbergen-vandeKaa C; van Basten JP; van Oort I; Witjes JA; Barentsz JO
    Invest Radiol; 2008 Oct; 43(10):686-94. PubMed ID: 18791410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.